Abstract PS10-09: Real-world analysis of concomitant medication use with potential drug-drug interactions (DDI) in patients with metastatic breast cancer (MBC) treated with cylin dependent kinase (CDK) 4/6 inhibitors
Rugo, Hope S., Balu, Sanjeev, Li, Yunfeng, Chen, Guifang, Li, Xin, Turner, Stuart, Sin, Roxana
Published in Cancer research (Chicago, Ill.) (15.02.2021)
Published in Cancer research (Chicago, Ill.) (15.02.2021)
Get full text
Journal Article
Abstract PS10-29: Comparison of healthcare resource utilization and costs in women with HR+/HER2- metastatic breast cancer treated with ribociclib vs palbociclib or abemaciclib
Balu, Sanjeev, Burne, Rebecca, Guerin, Annie, Bungay, Rebecca, Paul, Mary Lisha, Sin, Roxana
Published in Cancer research (Chicago, Ill.) (15.02.2021)
Published in Cancer research (Chicago, Ill.) (15.02.2021)
Get full text
Journal Article
Comparison of healthcare resource utilization and costs of patients with HR+/HER2- advanced breast cancer treated with ribociclib versus other CDK4/6 inhibitors
Burne, Rebecca, Balu, Sanjeev, Guérin, Annie, Bungay, Rebecca, Sin, Roxana, Paul, Mary Lisha
Published in Journal of medical economics (01.01.2021)
Published in Journal of medical economics (01.01.2021)
Get full text
Journal Article
Reduced Risk of Nocturnal-Confirmed Hypoglycemia with Insulin Degludec vs. Insulin Glargine in Patients with Type 1 Diabetes Requiring High Doses of Basal Insulin: a Meta-analysis of 2 Randomized Trials
Rodbard, Helena W, Handelsman, Yehuda, Gough, Stephen C.L, Hobbs, Todd M, Korsholm, Lars, Sin, Roxana, Lane, Wendy
Published in Canadian journal of diabetes (01.10.2013)
Published in Canadian journal of diabetes (01.10.2013)
Get full text
Journal Article